Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope

Rupinderjeet Kaur1, Manish Rauthan, Sudhanshu Vrati

  • 1Virology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, JNU Complex, New Delhi 110067, India.

Vaccine
|July 13, 2004
PubMed

Insights

Adsorbing Japanese encephalitis virus (JEV) DNA onto cationic microparticles enhanced antibody production compared to naked DNA. This method shows promise for improving DNA vaccine efficacy against JEV.

Area of Science:

  • Immunology
  • Virology
  • Biotechnology

Background:

  • Japanese encephalitis virus (JEV) poses a significant public health threat.
  • Plasmid DNA vaccines offer a potential strategy for JEV prevention.
  • Enhancing the immunogenicity of DNA vaccines is crucial for improved efficacy.

Purpose of the Study:

  • To evaluate the immunogenicity of JEV DNA vaccine (pMEa) adsorbed onto cationic microparticles.
  • To compare the immune responses elicited by microparticle-adsorbed DNA versus naked DNA.
  • To assess the potential of microparticle-adsorbed DNA for enhancing JEV vaccine efficacy.

Main Methods:

  • Adsorption of plasmid pMEa encoding JEV envelope protein onto cationic microparticles.
  • Intramuscular immunization of mice with microparticle-adsorbed DNA and naked DNA.
  • Quantification of anti-JEV antibody titers using ELISA.
  • Assessment of JEV neutralization titers.
  • Analysis of T-helper cell responses (Th1/Th2).

Main Results:

  • Microparticle-adsorbed JEV DNA induced significantly higher anti-JEV antibody titers compared to naked DNA.
  • No significant difference was observed in JEV neutralization titers between the two groups.
  • Naked DNA elicited a Th1 immune response, while microparticle-adsorbed DNA induced a mixed Th1-Th2 response.

Conclusions:

  • Cationic microparticles enhance the humoral immune response to JEV DNA vaccines.
  • The mixed Th1-Th2 response induced by microparticle-adsorbed DNA may offer broader protection.
  • Further studies are warranted to optimize microparticle-based JEV DNA vaccines for improved efficacy.

Related Concept Videos